Abstract:The PAK (p21-activated kinases) family is a class of intracellular signal transduction protein kinases that regulate various cellular functions, mainly through their interactions with small GTP enzymes. PAK1 and PAK2 in the PAK kinase family are key signal transduction molecules that play important roles in various biological processes, including morphological changes, migration, proliferation, and apoptosis, and are involved in the progression of many diseases. Abnormal expression or dysregulation of PAK1 and PAK2 may be associated with several diseases, including cancer, neurological diseases, etc. The current research mainly focuses on studying the role of PAK and PAK inhibitors in the regulation of cancer progression, but relatively few reports are available that explore their potential role in cardiovascular diseases. Vascular injury and repair are complex processes involved in many cardiovascular conditions, including atherosclerosis, restenosis, and hypertension. Emerging research suggests that PAK1 and PAK2 have pivotal roles in vascular endothelial cell functions, including migration, proliferation, and angiogenesis. These kinases also modulate vascular smooth muscle relaxation, vascular permeability, and structural alterations, which are critical in the development of atherosclerosis and vascular inflammation. By targeting these activities, PAK proteins are essential for both normal vascular physiology and the pathogenesis of vascular diseases, highlighting their potential as therapeutic targets for vascular health. This review focuses on recent studies that offer experimental insights into the mechanisms by which PAK1 and PAK2 regulate the biological processes of vascular injury and repair and the therapeutic potential of the current existing PAK inhibitors in vascular-related diseases. The limitations of treatment with some PAK inhibitors and the ways that future development can overcome these challenges are also discussed.

Biology of the p21-Activated Kinases

P-21 Activated Kinases in Liver Disorders

PAK signaling in oncogenesis

The Research Progress of P21 Activated Kinases

Molecular Pathways: Targeting P21-Activated Kinase 1 Signaling in Cancer--opportunities, Challenges, and Limitations.

P21-Activated Kinases and Gastrointestinal Cancer

A role for class I PAKs in the regulation of the excitability of the actin cytoskeleton.

P21-activated Kinase 1 and Breast Cancer

[P21-Activated Kinases and Their Role in the Nervous System].

Direct Interaction of P21-Activated Kinase 4 with PDZ-RhoGEF, a G Protein-linked Rho Guanine Exchange Factor*

The Mechanism of P21-Activated Kinase 2 Autoactivation

PAKs in Human Cancer Progression: From Inception to Cancer Therapeutic to Future Oncobiology.

Regulation Of The P21-Activated Kinase (Pak) By A Human G Beta-Like Wd-Repeat Protein, Hpip1

Regulation of Vascular Injury and Repair by P21-Activated Kinase 1 and P21-Activated Kinase 2: Therapeutic Potential and Challenges

The Role of P21-Activated Kinases in Pancreatic Cancer.

Small Molecules That Allosterically Inhibit P21-Activated Kinase Activity by Binding to the Regulatory P21-Binding Domain.

Regulation of Cancer Metastasis by PAK2

Group I Paks Function Downstream of Rac to Promote Podosome Invasion During Myoblast Fusion in Vivo

P21-Activated Kinase 1 (PAK1) Can Promote ERK Activation in a Kinase-independent Manner

PAK is essential for RAS-induced upregulation of cyclin D1 during the G(1) to S transition